India  

Fire has no impact on 'Covishield' vaccine production: Serum Institute of India

Video Credit: ANI - Duration: 01:16s - Published
Fire has no impact on 'Covishield' vaccine production: Serum Institute of India

Fire has no impact on 'Covishield' vaccine production: Serum Institute of India

Serum Institute of India (SII) CEO Adar Poonawalla on January 22 informed that there is no impact of fire on the production of 'Covishield' vaccine.

"The extent of the damage is more than 1,000 crores.

The supply of COVID-19 will not be affected due to the fire (at Serum Institute of India facility).

No actual vaccine was being made at that facility.

The fire has no impact on the production of 'Covishield' vaccine and no damage has occurred to the existing stock either," said Adar Poonawalla.

A major fire had occurred at Pune-based Serum Institute of India (SII) on January 21 that claimed 5 lives also.


You Might Like


💡 newsR Knowledge: Other News Mentions

COVID-19 COVID-19 Contagious disease caused by SARS-CoV-2

Cure or Threat? Wuhan Lab's New Intranasal Vaccine Sparks Fears of Another Covid-like Crisis [Video]

Cure or Threat? Wuhan Lab's New Intranasal Vaccine Sparks Fears of Another Covid-like Crisis

A new intranasal vaccine developed by researchers at the Wuhan lab has recently been unveiled, promising a novel approach to combating infectious diseases. However, this breakthrough has also sparked significant controversy and concern. While the vaccine’s potential to offer a more accessible and efficient method of vaccination is hailed as a major advancement, its origins and the circumstances surrounding its development are raising alarms about a possible new health crisis. Critics worry that the technology used in this vaccine could inadvertently lead to another pandemic-like scenario if not carefully monitored. As the world cautiously watches, the vaccine's rollout is stirring a heated debate about safety, preparedness, and the ethical implications of such advanced biological research. #IntranasalVaccine #WuhanLab #CovidCrisis #HealthFears #VaccineDebate #PandemicRisk #BioResearch #VaccineDevelopment #PublicHealth #InfectiousDiseases #SafetyConcerns #GlobalHealth #VaccineInnovation #EthicalIssues #HealthSecurity ~HT.97~PR.152~

Credit: Oneindia    Duration: 03:29Published

Pune Pune City in Maharashtra, India

SC denies dad of minor in Pune Porsche crash pre-arrest bail

The Supreme Court of India has rejected the anticipatory bail plea of a father accused of tampering with evidence to protect his minor son. The son was allegedly..
IndiaTimes

BJP rebel Shetty quits race, Sena's Sarvankar stays in fray

The BJP and the Maha Vikas Aghadi faced rebel candidates in the Maharashtra assembly polls, despite attempts to consolidate support. Several high-profile..
IndiaTimes

Pune: 35-year-old man killed by speeding car while bursting firecrackers on Diwali, video surfaces

Residents of the locality have demanded strict action against the accused driver and warned of a protest if the police fail to apprehend him, it was stated.
DNA

Related news from verified sources

Adar Poonawalla reassures Covishield production won't be affected, tweets 'no lives lost' in SII fire

A major fire broke out at a building inside Terminal Gate 1 of the Serum Institute of India (SII) in...
DNA - Published


Related videos from verified sources

Covishield vaccine ready for dispatch from Mumbai airport to Oman [Video]

Covishield vaccine ready for dispatch from Mumbai airport to Oman

Serum Institute of India's (SII) vaccine consignment will be dispatched from Mumbai's Chhatrapati Shivaji Maharaj International Airport on January 30. The consignment containing Covishield vaccine will..

Credit: ANI     Duration: 01:51Published
Covid update: SII seeks Novavax trial approval; virus may affect sperm quality [Video]

Covid update: SII seeks Novavax trial approval; virus may affect sperm quality

From Delhi schools opening for Classes 9 and 11 to SII seeking trial approval for the Novavax vaccine, here are the top updates on the pandemic. Delhi government on Friday announced the schools for..

Credit: HT Digital Content     Duration: 03:20Published
Novavax appears effective against UK variant [Video]

Novavax appears effective against UK variant

Novavax says its coronavirus vaccine was 89.3% effective in preventing COVID-19 in a trial conducted in the United Kingdom, and was nearly as effective in protecting against the more highly contagious..

Credit: Reuters Studio     Duration: 01:28Published